Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 14,878Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Strides Pharma Science

02 2Annora Pharma

03 2AstraZeneca

04 2Aurobindo Pharma Limited

05 2Rising Pharmaceuticals Inc

06 2XYZ Pharma

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : RX

Registration Country : USA

ZAFIRLUKAST

Brand Name : ACCOLATE

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 1996-09-26

Application Number : 20547

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : RX

Registration Country : USA

ZAFIRLUKAST

Brand Name : ACCOLATE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1999-09-17

Application Number : 20547

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Zafirlukast

Brand Name :

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Zafirlukast

Brand Name :

Dosage Form : Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2020-09-10

Application Number : 212475

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 2020-09-10

Application Number : 212475

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Zafirlukast

Brand Name : Accoleit

Dosage Form : Zafirlukast 20Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 20 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Zafirlukast

Brand Name : Accolate 20

Dosage Form : TAB

Dosage Strength : 20mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2023-11-27

Application Number : 213163

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 2023-11-27

Application Number : 213163

Regulatory Info : RX

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2022-08-25

Application Number : 204928

Regulatory Info : RX

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 2022-08-25

Application Number : 204928

Regulatory Info : RX

Registration Country : USA

blank

13

XYZ Pharma

2024 ACI Convention
Not Confirmed
arrow

XYZ Pharma

arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2010-11-18

Application Number : 90372

Regulatory Info : RX

Registration Country : USA

blank

14

XYZ Pharma

2024 ACI Convention
Not Confirmed
arrow

XYZ Pharma

arrow
2024 ACI Convention
Not Confirmed

ZAFIRLUKAST

Brand Name : ZAFIRLUKAST

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date : 2010-11-18

Application Number : 90372

Regulatory Info : RX

Registration Country : USA

blank